Summary & Key Points
"Did you know? PAC-CI has been committed early on to the fight against opportunistic infections. From its inception, the PAC-CI Programme has addressed a major public health challenge: combating opportunistic infections in people living with HIV."
Did you know?
PAC-CI has been committed early on to combating opportunistic infections
From its inception, the PAC-CI Program tackled a major public health challenge: fighting opportunistic infections in people living with HIV.
Opportunistic infections are diseases that occur more easily when the immune system is weakened. In the case of HIV, they posed a particularly serious threat to patients in the 1990s, especially in a context where antiretroviral treatments were still largely inaccessible in sub-Saharan Africa.
Faced with this situation, a key question arose: how could people living with HIV be better protected against these serious diseases, at a time when therapeutic options remained limited?
It was in this context that PAC-CI conducted a major trial in Côte d’Ivoire: the COTRIMO CI trial. This study is among the first major research projects that helped build the Program’s reputation in the health field.
Through this trial, PAC-CI contributed to finding concrete solutions to improve care for the most vulnerable patients.
In our next article, discover what the COTRIMO trial demonstrated and how its results marked a turning point in the prevention of opportunistic infections.
Christian KOUADIO
Clinical Research Associate and Communications Manager at PAC-CI
Contact the author
